NSC 625987 is primarily investigated for its potential in cancer research, particularly in studying its effects on tumor growth and cellular pathways. It has shown promise in laboratory settings as a compound that may inhibit the proliferation of certain cancer cells, making it a candidate for further development in oncology. Researchers are exploring its mechanisms of action, focusing on its ability to interfere with specific molecular targets involved in cancer progression. Additionally, NSC 625987 is being evaluated for its potential to enhance the efficacy of existing cancer therapies when used in combination treatments. Its role in preclinical studies contributes to the broader understanding of novel therapeutic strategies for combating various types of cancer.